The Congo announced the start of an epidemic due to an increase in Ebola virus cases in the Kasai province. This was reported by the World Health Organization (WHO).
It is reported that at least 28 patients are suspected of having the virus in the Bulape and Mweka health zones of Kasai province. 15 people have died, 4 of whom are healthcare workers.
Symptoms noted include fever, vomiting, diarrhea, and bleeding. On September 3, the Ebola virus—specifically the Zaire strain—was identified in samples taken at the National Biomedical Research Institute in the capital, Kinshasa. A national rapid response team, along with WHO experts in epidemiology, infection control, laboratory, and case management, have been deployed to the province to combat the epidemic.
Additionally, awareness work about the virus is being carried out for the local population. The delivery of 2 tons of medical equipment, personal protective equipment, and mobile laboratory equipment to the country is planned.
The capital, Kinshasa, currently has a stock of the Ervebo vaccine, which is considered effective against this virus, and 2,000 doses will be delivered to Kasai province soon. The vaccine is intended primarily for healthcare workers and those who have been in contact with patients.
"We are taking decisive measures to stop the spread of the virus and protect the population. The Congo has vast experience in managing such epidemics. In close collaboration with health officials, we will quickly scale up critical measures," said Dr. Matshidiso Moeti, WHO Regional Director for Africa.
Ebola is a rare but very dangerous and often fatal viral disease. The virus is transmitted from animals to humans and then spreads through the blood and body fluids of infected people.
